UHL-GROUP

UHL-Group Phospholipidforschung

WELCOME to the

AG UHL
Phospholipid-based Research

More than ever before, phospholipids represent the basis for innovative nanoformulations such as liposomes, lipid nanoparticles and micelles.

The research and teaching of our group focus on phospholipid-containing dosage forms.

For more information please attend the "Research" page.
In particular, we focus on translational research projects. This is performed in collaboration with academic institutions as well as industrial partners.

JunProf. Dr. Philipp Uhl
Lipoid-endowed professorship

Ruprecht-Karls-University Heidelberg

Institute of Pharmacy and Molecular Biotechnology

Department of Pharmaceutical Technology and Biopharmacy

The expertise of our group is based on:

Nanopartikuläre Transportsysteme

Preparation and characterization of nanoparticulate transport systems (liposomes, micelles, polymer nanoparticles).

Tetraether lipids

Isolation of tetraether lipids and incorporation into nanoparticulate transport systems.

CPP-konjugat-Synthese

Peptide synthesis as well as conjugation to active substances or nanoparticulate transport systems.

Rodent Studies

Design and performance of rodent studies (pharmacokinetics, biodistribution).

We are happy to get in contact with you.

JunProf. Dr. Philipp Uhl

Lipoid-endowed professorship

Ruprecht-Karls-University Heidelberg

Institute of Pharmacy and Molecular Biotechnology

Department of Pharmaceutical Technology and Biopharmacy

Im Neuenheimer Feld 329

69120 Heidelberg

News from the UHL-GROUP

Neue Publikation in Journal of Controlled Release

Neue Publikation in Journal of Controlled Release

Datum 14.11.2025 Neue Publikation in Journal of Controlled Release Wir freuen uns über die kürzlich akzeptierte Publikation im Journal…

PHOENIX Pharmazie Wissenschaftspreis für Pharmazeutische Technologie

PHOENIX Pharmazie Wissenschaftspreis für Pharmazeutische Technologie

Datum 16.10.2025 PHOENIX Pharmazie Wissenschaftspreis für Pharmazeutische Technologie Wir freuen uns sehr, dass eine unserer Publikationen zur Oralisierung von…

Neue Förderung GO-Bio initial – BMFTR GO-Bio

Datum 06.10.2025 Neue Förderung GO-Bio initial – BMFTR GO-Bio Wir freuen uns über die Förderung unseres Antrags „Nanopartikuläre Plattform-Technologie…